Boji Medical Technology Co

Boji Medical Technology Co Interest Coverage

The Interest Coverage Ratio of Boji Medical Technology Co (300404.SZ) as of Nov 5, 2026 is 18.90. In the previous year, Interest Coverage Ratio was 9.79 — a change of 93.06% (higher).

Interest Coverage

18.90

YoY

93.06%

Last updated:

Interest Coverage Ratio of Boji Medical Technology Co is 2024 18.90 . Interest Coverage Ratio of Boji Medical Technology Co was 2023 9.79 . It decreases by 93.06% higher compared to the previous year.

The Boji Medical Technology Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-6.53 CNY
Jan 1, 2018
5.29 CNY
Jan 1, 2019
8.82 CNY
Jan 1, 2020
19.91 CNY
Jan 1, 2021
19.35 CNY
Jan 1, 2022
7.36 CNY
Jan 1, 2023
9.79 CNY
Jan 1, 2024
18.90 CNY
The Boji Medical Technology Co Interest Coverage history
YEARInterest CoverageYoY
18.90+93.06%
9.79+32.94%
7.36-61.95%
19.35-2.77%
19.91+125.68%
8.82+66.76%
5.29-181.01%
-6.53-60,698.84%
0.01-99.84%
6.85-84.06%
42.96—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Boji Medical Technology Co Stock analysis

What does Boji Medical Technology Co do? Boji Medical Technology Co., Ltd. generates revenue through comprehensive CRO services for pharmaceutical and medical device development. The company offers preclinical research, clinical trials, data management, biostatistics, and regulatory consulting, primarily serving domestic pharmaceutical companies and research institutions. Their one-stop service model includes drug evaluation, medical device registration, and CDMO services for new drug and device production. The firm's domestic market focus ensures steady demand from local clients seeking regulatory compliance and R&D support. The company's revenue streams are derived from multiple service segments: preclinical studies, clinical research, and technology transfer. These services are tailored to meet the needs of pharmaceutical firms requiring outsourced R&D solutions. CDMO services further enhance their offerings by supporting manufacturing processes alongside development. Domestic clients form the core customer base, leveraging Boji's expertise in navigating China's regulatory landscape for drug and device approvals. Boji Medical Technology's business model centers on providing end-to-end CRO solutions, combining preclinical and clinical research with regulatory support. Their services are designed to accelerate product development cycles for clients, reducing time-to-market for new pharmaceuticals and medical devices. The firm's domestic market strategy aligns with the growing demand for R&D outsourcing within China's healthcare sector. Boji Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boji Medical Technology Co stock

Interest Coverage Ratio of Boji Medical Technology Co is 18.90 in 2024.

Interest Coverage Ratio of Boji Medical Technology Co changed from 9.79 to 18.90, representing a 93.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Boji Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Boji Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Boji Medical Technology Co

All Key Metrics — Boji Medical Technology Co